NCT04556019 Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit
| NCT ID | NCT04556019 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Miguel Servet |
| Condition | Pancreas Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-01-03 |
| Primary Completion | 2024-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-01-03 with a primary completion date of 2024-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.
Eligibility Criteria
Inclusion Criteria: * All patients operated by the HPB Surgical Unit in the last 10 years (retrospective) * All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective). Exclusion Criteria: * Patients not eligible for surgery * Patients not interested in taking part in the study
Contact & Investigator
Francisco Javier Herrera Cabezón, MD
PRINCIPAL INVESTIGATOR
Complejo Hospitalario de Navarra
Frequently Asked Questions
Who can join the NCT04556019 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 90 Years, studying Pancreas Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04556019 currently recruiting?
Yes, NCT04556019 is actively recruiting participants. Contact the research team at javier.herrera.cabezon@cfnavarra.es for enrollment information.
Where is the NCT04556019 trial being conducted?
This trial is being conducted at Pamplona, Spain.
Who is sponsoring the NCT04556019 clinical trial?
NCT04556019 is sponsored by Fundacion Miguel Servet. The principal investigator is Francisco Javier Herrera Cabezón, MD at Complejo Hospitalario de Navarra. The trial plans to enroll 1,000 participants.